Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Biomind Labs Inc N.BMND

Alternate Symbol(s):  BMNDF

Biomind Labs Inc. is a biotech research and development company. It is focused on transforming biomedical sciences knowledge into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, Biomind Labs is developing novel pharmaceutical formulations of key endogenous substances which are occurring in the human body and an organic compound that includes many neurotransmitters for treating a range of therapeutic indications. DMT is a serotonergic psychedelic that exerts its effects through serotonergic receptors in the brain, including 5-HT2A, 5-HT1A, 5-HT2C and 5-HT7 receptors. 5-MeO-DMT is a powerful psychedelic tryptamine. Under the 5-MeO-DMT Program, it is focused on two drug candidates: BMND05: 5-MeO-DMT novel formulation indicated for Chronic Pain and BMND08: 5-MeO-DMT novel formulation indicated for Alzheimer’s disease. Mescaline is a psychedelic alkaloid of the phenethylamine class.


NEO:BMND - Post by User

Bullboard Posts
Comment by DTM5on Apr 22, 2010 7:25pm
296 Views
Post# 17021781

RE: RE: RE: RE: Silence...

RE: RE: RE: RE: Silence...Rational2, very interesting comments.
I'd say that clearly there is a deal afoot - otherwise the market (the 'leaky' canadian market especially) would have this priced around a dollar or less.  And quickly.
What type of deal is anyones guess.   I wasn't a seller at this level previously, as I do believe in the company's value.    I did sell approx 50% of my shares in the 1.50s.   At this point, I am considering that I should have sold them all in that region;  The potential extra 10 or 20 cents above that  has not been worth the uncertainty - especially in terms of other market opportunities recently.
Ironically, if I sell at current levels my average sale price will be about the same as maxam's final offer.  
I'm not angry or on an 'anti driscol' vendetta.   I know the risks of investing in these types of companies.   And I think the management of the company has been competent and capable in executing their vision.  There was a little thing called the global financial meltdown that really threw the whole project - and markets - way off track.   The good news is that I was an active buyer sub $1.   
That being said, there is a smell emanating from the company right now - The (lack of) action and coercive press releases (and aggressive recommendation not to tender) are looking VERY self serving to the company's senior management and directors right now.   What was an opportunity seems to be turning bad.  Its almost time to sell into the market and forgo any diminishing possibility of an extra 40 cents.....
Bullboard Posts